Analyst Ratings for Nautilus Biotechnology (NAUT)
NAUT Rating Summary
NAUT Price Target Summary
- Highest: $4.00 (Guggenheim)
- Lowest: $4.00 (Guggenheim)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.00 (+292.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$4.00 (+292.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.93 (1.02) |
9.68% | Details |
| 12/5/2024 | Goldman Sachs » Updated 2/28/2025 |
Matthew Sykes | Downgrade | Sell (Neutral) |
1.00 (1.75) |
2.18 (1.02) |
-53.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
